{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:29:25Z","timestamp":1790814565096,"version":"4.1.0"},"reference-count":64,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Materials"],"abstract":"<jats:p>Cancers still remain one of the most significant challenges in medicine or pharmacy, accounting for nearly 10 million deaths annually and imposing a substantial socioeconomic burden worldwide. Although chemotherapy continues to play a central role in the treatment of many tumors, conventional anticancer therapies are frequently associated with poor selectivity, systemic toxicity, multidrug resistance, and unfavorable pharmacokinetic profiles. Paclitaxel (PTX), one of the most widely used antineoplastic agents, demonstrates remarkable clinical efficacy against breast, ovarian, lung, pancreatic, and several other malignancies. Nevertheless, its clinical application remains limited by poor aqueous solubility, non-specific biodistribution, dose-limiting toxicities, and the development of resistance mechanisms. Nanotechnology-based anticancer drug delivery systems have emerged as a promising strategy to address these limitations. Among them, polymeric nanosystems have attracted particular attention owing to their physicochemical properties, biocompatibility, controlled drug-release capabilities, and potential for tumor-targeted delivery. Natural, semi-synthetic, and synthetic polymers are extensively investigated as carriers for PTX, leading to the development of nanoparticles, micelles, nanogels, nanofibers, dendritic systems, and hybrid nanoplatforms. Nanosystems demonstrate enhanced therapeutic efficacy, reduced systemic toxicity, prolonged circulation times, and improved tumor accumulation in preclinical models. Despite encouraging laboratory results, the clinical translation of polymeric PTX nanocarriers (NCs) remains limited. Numerous barriers, including tumor heterogeneity, variability of the enhanced permeability and retention (EPR) effect, manufacturing complexity, regulatory challenges, scale-up difficulties, and discrepancies between animal models and human cancers, continue to hinder successful commercialization and widespread clinical adoption. This review critically discusses the current state of polymeric drug delivery systems (DDSs) that contain PTX, as well as the advantages and limitations of synthetic, natural, and semi-synthetic polymers used in DDS technologies. Furthermore, translational challenges and future perspectives of PTX-based DDSs were analyzed.<\/jats:p>","DOI":"10.3390\/ma19142999","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:05:31Z","timestamp":1783929931000},"page":"2999","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polymeric Therapeutic Nanosystems Containing Paclitaxel: Novel Strategies, Therapeutic Potential, Challenges, and Translation Problems"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7362-8881","authenticated-orcid":false,"given":"Marcin","family":"Sobczak","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Str., 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-1618","authenticated-orcid":false,"given":"Karolina","family":"K\u0119dra","sequence":"additional","affiliation":[{"name":"Institute of Physical Chemistry, Polish Academy of Sciences, 44\/52 Kasprzaka Str., 01-224 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100216","DOI":"10.1016\/j.nwnano.2026.100216","article-title":"Natural polysaccharide-derived nanocarriers for targeted paclitaxel delivery in cancer therapy: Recent progress and future directions","volume":"14","author":"Badikol","year":"2026","journal-title":"Nano Trends"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"119585","DOI":"10.1016\/j.biopha.2026.119585","article-title":"Integrative co-delivery platforms for paclitaxel: Advancing synergistic breast cancer therapy","volume":"200","author":"Almalki","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"174512","DOI":"10.1016\/j.ejphar.2021.174512","article-title":"Strategies for active tumor targeting-an update","volume":"915","author":"Vyas","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., and Cosco, D. (2021). Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.601626"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12272-026-01609-w","article-title":"Recent paclitaxel formulation strategies: Expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations","volume":"49","author":"Lee","year":"2026","journal-title":"Arch. Pharmacal Res."},{"key":"ref_7","first-page":"59","article-title":"Systematic Patent Review of Nanoparticles in Drug Delivery and Cancer Therapy in the Last Decade","volume":"15","author":"Hazis","year":"2021","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sobczak, M. (2022). Enzyme-Responsive Hydrogels as Potential Drug Delivery Systems\u2014State of Knowledge and Future Prospects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084421"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1039\/D0BM00558D","article-title":"The regulation of nanomaterials and nanomedicines for clinical application: Current and future perspectives","volume":"8","author":"Foulkes","year":"2020","journal-title":"Biomater. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1039\/D4BM00480A","article-title":"Uniform block copolymer nanofibers for the delivery of paclitaxel in 2D and 3D glioblastoma tumor models","volume":"12","author":"Parkin","year":"2024","journal-title":"Biomater. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e22900","DOI":"10.1002\/jbt.22900","article-title":"The current knowledge concerning solid cancer and therapy","volume":"35","author":"Najafi","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1208\/s12249-026-03414-6","article-title":"Recent Advances in Surface-Engineered Polymeric Nanoparticles for Targeted Paclitaxel Delivery in Breast Cancer Therapy","volume":"27","author":"Fatima","year":"2026","journal-title":"AAPS PharmSciTech"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101613","DOI":"10.1016\/j.jddst.2020.101613","article-title":"Recent advances in folic acid engineered nanocarriers for treatment of breast cancer","volume":"56","author":"Tagde","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wyr\u0119biak, R., Figat, R., Oledzka, E., Kasinski, A., K\u0119dra, K., Laskowska, A., and Sobczak, M. (2025). Exploration of a Novel Catalytic Approach for Synthesizing Glycolide and \u03b5-Caprolactone Copolymers and Their Application as Carriers for Paclitaxel. Molecules, 30.","DOI":"10.3390\/molecules30112318"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kotta, S., Aldawsari, H.M., Badr-Eldin, S.M., Nair, A.B., and Kamal, Y.T. (2022). Progress in Polymeric Micelles for Drug Delivery Applications. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081636"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"118840","DOI":"10.1016\/j.ijpharm.2019.118840","article-title":"Evaluation of intestinal permeation enhancement with carboxymethyl chitosan-rhein polymeric micelles for oral delivery of paclitaxel","volume":"573","author":"Wang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"025018","DOI":"10.1088\/2043-6262\/7\/2\/025018","article-title":"Development of chitosan graft pluronic\u00aeF127 copolymer nanoparticles containing DNA aptamer for paclitaxel delivery to treat breast cancer cells","volume":"7","author":"Nguyen","year":"2016","journal-title":"Adv. Nat. Sci. Nanosci. Nanotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.carbpol.2011.04.082","article-title":"Paclitaxel loaded electrospun porous nanofibers as mat potential application for chemotherapy against prostate cancer","volume":"86","author":"Ma","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"123380","DOI":"10.1016\/j.ijbiomac.2023.123380","article-title":"Paclitaxel-loaded liposome-incorporated chitosan (core)\/poly(\u03b5-caprolactone)\/chitosan (shell) nanofibers for the treatment of breast cancer","volume":"230","author":"Hasanbegloo","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/10717544.2018.1477863","article-title":"L-peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells","volume":"25","author":"Niu","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"136141","DOI":"10.1016\/j.colsurfa.2025.136141","article-title":"Folic acid-grafted poly-3-hydroxybutyrate nanoparticles for enhanced pH-sensitive paclitaxel delivery and cancer cell targeting","volume":"170","author":"Aslam","year":"2025","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_22","first-page":"2101","article-title":"Folate- modified lipid\u2013polymer hybrid nanoparticles for targeted paclitaxel delivery","volume":"10","author":"Zhang","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"119105","DOI":"10.1016\/j.ijpharm.2020.119105","article-title":"Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy","volume":"578","author":"Chen","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.actbio.2015.08.029","article-title":"Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid","volume":"26","author":"Yin","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijbiomac.2014.08.054","article-title":"Paclitaxel loaded hyaluronic acid nanoparticles for targeted cancer therapy: In vitro and in vivo analysis","volume":"72","author":"Thomas","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gote, V., Sharma, A.D., and Pal, D. (2021). Hyaluronic acid-targeted stimuli- sensitive nanomicelles co-encapsulating paclitaxel and ritonavir to overcome multi-drug resistance in metastatic breast cancer and triple-negative breast cancer cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031257"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1039\/C7TB01510K","article-title":"Hybrid nanoparticles coated with hyaluronic acid lipoid for targeted co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells","volume":"5","author":"Yang","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ning, Q., Yu, G., Yi, W., Gu, M., Xu, Q., Ye, Z., Zhang, M., and Tang, S. (2025). Development of GSH-Stimuli-Responsive Micelles Using a Targeted Paclitaxel Prodrug for Enhanced Anticancer Effect. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17040538"},{"key":"ref_29","first-page":"1038","article-title":"Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel","volume":"8","author":"Ibrahim","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"015101","DOI":"10.1088\/1361-6528\/abb55a","article-title":"Paclitaxel-loaded lignin particle encapsulated into electrospun PVA\/PVP composite nanofiber for effective cervical cancer cell inhibition","volume":"32","author":"Li","year":"2021","journal-title":"Nanotechnology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2306230","DOI":"10.1002\/advs.202306230","article-title":"Enzyme-Responsive Branched Glycopolymer-Based Nanoassembly for Co-Delivery of Paclitaxel and Akt Inhibitor toward Synergistic Therapy of Gastric Cancer","volume":"11","author":"Song","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102751","DOI":"10.1016\/j.nano.2024.102751","article-title":"Riboflavin-targeted polymers improve tolerance of paclitaxel while maintaining therapeutic efficacy","volume":"58","author":"Darguzyte","year":"2024","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_33","first-page":"26690\u221226703","article-title":"Paclitaxel Prodrug Enables Glutathione Depletion to Boost Cancer Treatment","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.msec.2016.01.059","article-title":"Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anti- cancer delivery: Characterization and cellular cytotoxicity","volume":"62","author":"Darvishi","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"104608","DOI":"10.1016\/j.reactfunctpolym.2020.104608","article-title":"Multifunctional micelles self-assembled from hyaluronic acid conjugate for enhancing anti-tumor effect of paclitaxel","volume":"152","author":"Li","year":"2020","journal-title":"React. Funct. Polym."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1158\/1078-0432.CCR-03-0655","article-title":"Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies","volume":"10","author":"Kim","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e20295","DOI":"10.1016\/j.heliyon.2023.e20295","article-title":"An exploratory research on antitumor effect of drug-eluting slow-releasing electrospinning membranes","volume":"9","author":"Li","year":"2023","journal-title":"Heliyon"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10924-023-02970-3","article-title":"Tri-layered Polycaprolactone\/Taxol\/Gelatin\/5-FU Nanofibers Against MCF-7 Breast Cancer Cells","volume":"32","author":"Najjari","year":"2023","journal-title":"J. Polym. Environ."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/sj.bjc.6602479","article-title":"NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel","volume":"92","author":"Hamaguchi","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11539","DOI":"10.2147\/IJN.S488369","article-title":"Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug","volume":"19","author":"Wu","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1021\/acs.molpharmaceut.3c00596","article-title":"Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method","volume":"20","author":"Jaradat","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.biomaterials.2009.11.047","article-title":"Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature","volume":"31","author":"Yu","year":"2010","journal-title":"Biomaterials"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chi, H.Y., Chan, V., Li, C., Hsieh, J.H., Lin, P.H., Tsai, Y.-H., and Chen, Y. (2020). Fabrication of polylactic acid\/paclitaxel nano fibers by electrospinning for cancer therapeutics. BMC Chem., 14.","DOI":"10.1186\/s13065-020-00711-4"},{"key":"ref_44","first-page":"186","article-title":"Investigation of drug release from paclitaxel loaded polylactic acid nanofibers","volume":"3","author":"Doustgani","year":"2016","journal-title":"Nanomed. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2147\/NSA.S560473","article-title":"Paclitaxel-Loaded Polyelectrolyte Nanocarriers: Uptake Mechanisms, Cytotoxicity, and Genotoxicity in Human Endothelial and Breast Cancer Cells","volume":"18","author":"Szwed","year":"2025","journal-title":"Nanotechnol. Sci. Appl."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Szwed, M., Poczta-Krawczyk, A., Kania, K.D., Wiktorowski, K., Podsiad\u0142o, K., Marczak, A., and Szczepanowicz, K. (2025). Multicore, SDS-Based Polyelectrolyte Nanocapsules as Novel Nanocarriers for Paclitaxel to Reduce Cardiotoxicity by Protecting the Mitochondria. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26030901"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2019.01.046","article-title":"Poly(D,L-lactide)\/polyethylene glycol micro\/nanofiber mats as paclitaxel-eluting carriers: Preparation, characterization, in vitro release, antiangiogenic activity and tumor recurrence prevention","volume":"98","author":"Hobzova","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"109121","DOI":"10.1016\/j.biopha.2019.109121","article-title":"HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation","volume":"117","author":"Duan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.colsurfb.2016.03.075","article-title":"Cd44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomy- cin and paclitaxel","volume":"143","author":"Muntimadugu","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e02235","DOI":"10.1002\/slct.202502235","article-title":"Engineering FA-Modified Lipid\u2013Polymer Nanocapsules for the Selective Delivery of Paclitaxel and Doxorubicin in Breast Cancer Treatment","volume":"10","author":"Nankali","year":"2025","journal-title":"ChemistrySelect"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Hsu, M.Y., Hsieh, C.H., Huang, Y.T., Chu, S.Y., Chen, C.M., Lee, W.J., and Liu, S.J. (2021). Enhanced Paclitaxel Efficacy to Suppress Triple-Negative Breast Cancer Progression Using Metronomic Chemotherapy with a Controlled Release System of Electrospun Poly-d-l-Lactide-Co-Glycolide (PLGA) Nanofibers. Cancers, 13.","DOI":"10.3390\/cancers13133350"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1166\/jbn.2015.1827","article-title":"Controlled Dual Drug Release and In Vitro Cytotoxicity of Electrospun Poly(lactic-co-glycolic acid) Nanofibers Encapsulated with Micelles","volume":"11","author":"Liu","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.procbio.2024.04.007","article-title":"Leucocyte membrane camouflaged poly-lactic-co-glycolic acid (PLGA) nanoparticles containing cannabidiol and paclitaxel against breast cancer therapy","volume":"142","author":"Nadaf","year":"2024","journal-title":"Process Biochem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.ijbiomac.2020.07.228","article-title":"Synthesis of PLGA\/chitosan\/zeolites and PLGA\/chitosan\/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death","volume":"164","author":"Dizaji","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jmmm.2013.05.036","article-title":"Aptamer conjugated paclitaxel and magnetic fluid loaded fluorescently tagged PLGA nanoparticles for targeted cancer therapy","volume":"344","author":"Aravind","year":"2013","journal-title":"J. Magn. Magn. Mater."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ijbiomac.2019.10.120","article-title":"Synthesis of magnetic gold coated poly (\u03b5-caprolactonediol) based polyurethane\/poly(N-isopropylacrylamide)-grafted-chitosan core-shell nanofibers for controlled release of paclitaxel and 5-FU","volume":"150","author":"Farboudi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2005.09.033","article-title":"Paclitaxel poliglumex (XYOTAX, CT-2103): A macromolecular taxane","volume":"109","author":"Singer","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1016\/j.biomaterials.2011.03.061","article-title":"Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel","volume":"32","author":"Shahin","year":"2011","journal-title":"Biomaterials"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Rezk, A.I., Park, J., Moon, J.Y., Lee, S., Park, C.H., and Kim, C.S. (2021). A Novel Design of Tri-Layer Membrane with Controlled Delivery of Paclitaxel and Anti-Biofilm Effect for Biliary Stent Applications. Nanomaterials, 11.","DOI":"10.3390\/nano11020486"},{"key":"ref_60","first-page":"4537","article-title":"Antitumor effect of the paclitaxel-eluting membrane in a mouse model","volume":"16","author":"Park","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_61","first-page":"422","article-title":"Enhancement of Paclitaxel Therapeutic Effect by Aptamer Targeted Delivery in PLGA Nanoparticles","volume":"5","author":"Dursun","year":"2022","journal-title":"Eurasian J. Med. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"118607","DOI":"10.1016\/j.biopha.2025.118607","article-title":"Nanofibers for paclitaxel delivery: A promising avenue for cancer therapy","volume":"192","author":"Noori","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s11095-006-9036-z","article-title":"Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro","volume":"23","author":"Xie","year":"2006","journal-title":"Pharm. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e2408813","DOI":"10.1002\/smll.202408813","article-title":"Localized Microrobotic Delivery of Enzyme-Responsive Hydrogel-Immobilized Therapeutics to Suppress Triple-Negative Breast Cancer","volume":"21","author":"Tian","year":"2025","journal-title":"Small"}],"container-title":["Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1996-1944\/19\/14\/2999\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:11:24Z","timestamp":1783930284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1996-1944\/19\/14\/2999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":64,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ma19142999"],"URL":"https:\/\/doi.org\/10.3390\/ma19142999","relation":{},"ISSN":["1996-1944"],"issn-type":[{"value":"1996-1944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}